Fulcrum Therapeutics IncNASDAQ:FULC
- LAST PRICE3.4400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.3300/ 1
- Ask / Lots3.5000/ 1
- Open / Previous Close--- / 3.4400
- Day Range---
- 52 Week Range
- Volume536
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FULC |
|---|---|---|
| 09:32 ET | 13862 | 3.43 |
| 09:34 ET | 6740 | 3.4 |
| 09:36 ET | 10595 | 3.425 |
| 09:38 ET | 4765 | 3.435 |
| 09:39 ET | 2369 | 3.43 |
| 09:41 ET | 25382 | 3.43 |
| 09:43 ET | 10608 | 3.45 |
| 09:45 ET | 2978 | 3.41 |
| 09:48 ET | 1522 | 3.44 |
| 09:50 ET | 5555 | 3.465 |
| 09:52 ET | 201 | 3.465 |
| 09:54 ET | 8298 | 3.465 |
| 09:56 ET | 4568 | 3.4512 |
| 09:57 ET | 14800 | 3.52 |
| 09:59 ET | 1100 | 3.51 |
| 10:01 ET | 4466 | 3.48 |
| 10:03 ET | 400 | 3.485 |
| 10:06 ET | 38362 | 3.47 |
| 10:08 ET | 6373 | 3.48 |
| 10:10 ET | 2907 | 3.46 |
| 10:12 ET | 1017 | 3.48 |
| 10:14 ET | 3221 | 3.49 |
| 10:15 ET | 300 | 3.49 |
| 10:17 ET | 7929 | 3.47 |
| 10:19 ET | 2087 | 3.48 |
| 10:21 ET | 3758 | 3.4812 |
| 10:24 ET | 3066 | 3.465 |
| 10:26 ET | 2600 | 3.47 |
| 10:28 ET | 769 | 3.48 |
| 10:30 ET | 1393 | 3.49 |
| 10:32 ET | 3030 | 3.491 |
| 10:33 ET | 3084 | 3.485 |
| 10:35 ET | 1000 | 3.475 |
| 10:37 ET | 2241 | 3.48 |
| 10:39 ET | 8711 | 3.48 |
| 10:42 ET | 8300 | 3.46 |
| 10:44 ET | 1279 | 3.49 |
| 10:46 ET | 3629 | 3.49 |
| 10:48 ET | 1000 | 3.47 |
| 10:50 ET | 800 | 3.47 |
| 10:51 ET | 1068 | 3.455 |
| 10:53 ET | 11578 | 3.46 |
| 10:55 ET | 3370 | 3.475 |
| 10:57 ET | 2853 | 3.48 |
| 11:00 ET | 2612 | 3.49 |
| 11:02 ET | 1624 | 3.49 |
| 11:04 ET | 2629 | 3.49 |
| 11:06 ET | 800 | 3.485 |
| 11:08 ET | 4808 | 3.488214 |
| 11:09 ET | 2925 | 3.48 |
| 11:11 ET | 1102 | 3.475 |
| 11:13 ET | 200 | 3.475 |
| 11:15 ET | 300 | 3.4712 |
| 11:18 ET | 6772 | 3.47 |
| 11:20 ET | 200 | 3.465 |
| 11:22 ET | 18399 | 3.445 |
| 11:24 ET | 6134 | 3.435 |
| 11:26 ET | 15394 | 3.43 |
| 11:27 ET | 918 | 3.4201 |
| 11:29 ET | 999 | 3.43 |
| 11:31 ET | 100 | 3.42 |
| 11:33 ET | 500 | 3.425 |
| 11:36 ET | 1800 | 3.43 |
| 11:38 ET | 115 | 3.43 |
| 11:40 ET | 300 | 3.42 |
| 11:42 ET | 1100 | 3.4383 |
| 11:44 ET | 13496 | 3.425 |
| 11:45 ET | 7725 | 3.42 |
| 11:47 ET | 6025 | 3.415 |
| 11:49 ET | 2513 | 3.405 |
| 11:51 ET | 7052 | 3.4 |
| 11:54 ET | 1918 | 3.41 |
| 11:56 ET | 1000 | 3.41 |
| 11:58 ET | 3947 | 3.415 |
| 12:00 ET | 926 | 3.4 |
| 12:02 ET | 100 | 3.4 |
| 12:03 ET | 1000 | 3.4 |
| 12:05 ET | 3349 | 3.3918 |
| 12:07 ET | 300 | 3.39 |
| 12:09 ET | 500 | 3.4 |
| 12:12 ET | 19510 | 3.42 |
| 12:14 ET | 2284 | 3.41 |
| 12:16 ET | 1961 | 3.406 |
| 12:18 ET | 1920 | 3.4 |
| 12:20 ET | 577 | 3.395 |
| 12:21 ET | 400 | 3.3901 |
| 12:23 ET | 400 | 3.395 |
| 12:25 ET | 1077 | 3.395 |
| 12:27 ET | 959 | 3.4 |
| 12:30 ET | 3336 | 3.3913 |
| 12:32 ET | 15186 | 3.385 |
| 12:34 ET | 800 | 3.38 |
| 12:36 ET | 500 | 3.37 |
| 12:38 ET | 3126 | 3.3609 |
| 12:39 ET | 1400 | 3.37 |
| 12:41 ET | 525 | 3.37 |
| 12:43 ET | 14633 | 3.35 |
| 12:45 ET | 7584 | 3.37 |
| 12:48 ET | 10688 | 3.4 |
| 12:50 ET | 3504 | 3.394 |
| 12:52 ET | 200 | 3.395 |
| 12:54 ET | 620 | 3.3988 |
| 12:56 ET | 1300 | 3.395 |
| 12:57 ET | 900 | 3.395 |
| 12:59 ET | 2045 | 3.405 |
| 01:01 ET | 206 | 3.405 |
| 01:06 ET | 8800 | 3.405 |
| 01:08 ET | 5051 | 3.405 |
| 01:10 ET | 1070 | 3.405 |
| 01:12 ET | 4031 | 3.3975 |
| 01:14 ET | 794 | 3.385 |
| 01:15 ET | 1300 | 3.39 |
| 01:17 ET | 500 | 3.385 |
| 01:19 ET | 1951 | 3.384 |
| 01:21 ET | 1805 | 3.38 |
| 01:24 ET | 15756 | 3.39 |
| 01:26 ET | 16088 | 3.381 |
| 01:28 ET | 1163 | 3.38 |
| 01:30 ET | 3143 | 3.37 |
| 01:32 ET | 2718 | 3.374 |
| 01:33 ET | 6436 | 3.38 |
| 01:35 ET | 5457 | 3.375 |
| 01:37 ET | 1794 | 3.375 |
| 01:39 ET | 500 | 3.375 |
| 01:42 ET | 7825 | 3.355 |
| 01:44 ET | 5480 | 3.345 |
| 01:46 ET | 3909 | 3.345 |
| 01:48 ET | 1427 | 3.345 |
| 01:50 ET | 11860 | 3.345 |
| 01:51 ET | 4750 | 3.345 |
| 01:53 ET | 16510 | 3.37 |
| 01:55 ET | 1944 | 3.36 |
| 01:57 ET | 3200 | 3.36 |
| 02:00 ET | 2158 | 3.365 |
| 02:02 ET | 31394 | 3.46 |
| 02:04 ET | 14732 | 3.493186 |
| 02:06 ET | 17102 | 3.481 |
| 02:08 ET | 5090 | 3.46 |
| 02:09 ET | 8093 | 3.41 |
| 02:11 ET | 5912 | 3.41 |
| 02:13 ET | 7706 | 3.395 |
| 02:15 ET | 8194 | 3.435 |
| 02:18 ET | 4300 | 3.46 |
| 02:20 ET | 3618 | 3.4786 |
| 02:22 ET | 1597 | 3.48 |
| 02:24 ET | 8882 | 3.4675 |
| 02:26 ET | 3382 | 3.48 |
| 02:27 ET | 7100 | 3.475 |
| 02:29 ET | 3162 | 3.49 |
| 02:31 ET | 2513 | 3.49 |
| 02:33 ET | 7587 | 3.5069 |
| 02:36 ET | 10475 | 3.53 |
| 02:38 ET | 10473 | 3.5 |
| 02:40 ET | 7759 | 3.525 |
| 02:42 ET | 3133 | 3.52 |
| 02:44 ET | 4695 | 3.505 |
| 02:45 ET | 6672 | 3.48 |
| 02:47 ET | 21899 | 3.485 |
| 02:49 ET | 8691 | 3.49 |
| 02:51 ET | 1600 | 3.4908 |
| 02:54 ET | 27095 | 3.55 |
| 02:56 ET | 5182 | 3.535 |
| 02:58 ET | 5539 | 3.55 |
| 03:00 ET | 6680 | 3.51 |
| 03:02 ET | 3900 | 3.48 |
| 03:03 ET | 5396 | 3.46 |
| 03:05 ET | 8152 | 3.475 |
| 03:07 ET | 9250 | 3.455 |
| 03:09 ET | 3387 | 3.4688 |
| 03:12 ET | 25266 | 3.465 |
| 03:14 ET | 17117 | 3.5099 |
| 03:16 ET | 16923 | 3.518 |
| 03:18 ET | 6336 | 3.49 |
| 03:20 ET | 10758 | 3.49 |
| 03:21 ET | 1800 | 3.465 |
| 03:23 ET | 8171 | 3.44 |
| 03:25 ET | 4551 | 3.45 |
| 03:27 ET | 5401 | 3.48 |
| 03:30 ET | 703 | 3.485 |
| 03:32 ET | 3944 | 3.48 |
| 03:34 ET | 3912 | 3.48 |
| 03:36 ET | 5147 | 3.475 |
| 03:38 ET | 3841 | 3.465 |
| 03:39 ET | 10041 | 3.475 |
| 03:41 ET | 7384 | 3.47 |
| 03:43 ET | 3264 | 3.475 |
| 03:45 ET | 3274 | 3.47 |
| 03:48 ET | 5571 | 3.46 |
| 03:50 ET | 7050 | 3.47 |
| 03:52 ET | 6428 | 3.475 |
| 03:54 ET | 5726 | 3.477 |
| 03:56 ET | 17402 | 3.455 |
| 03:57 ET | 8848 | 3.455 |
| 03:59 ET | 123426 | 3.44 |
Yesterday
Fulcrum Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - FULC, from 9 hours ago by Dow Jones
9 hours ago by Dow JonesFulcrum Therapeutics Inc Is Being Inquired Into For Securities Fraud And Affected Shareholders Should Contact The Schall Law Firm, from 10 hours ago by Dow Jones
10 hours ago by Dow JonesFulcrum Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - FULC, from 19 hours ago by Dow Jones
19 hours ago by Dow JonesFulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation, from 20 hours ago by Dow Jones
20 hours ago by Dow Jones
Sep 17, 2024
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Fulcrum Therapeutics, Inc. (FULC), from 5:46PM ET on Tuesday Sep 17, 2024 by Dow Jones
5:46PM ET on Tuesday Sep 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fulcrum Therapeutics Inc | 214.7M | -9.8x | --- |
Pyxis Oncology Inc | 215.7M | -2.9x | --- |
Cabaletta Bio Inc | 218.8M | -2.3x | --- |
ATAI Life Sciences NV | 208.1M | -3.2x | --- |
Abeona Therapeutics Inc | 236.1M | -2.6x | --- |
Gossamer Bio Inc | 206.1M | -2.3x | --- |
Company Information
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. The Company’s clinical product candidate, losmapimod, is developed for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Its other clinical product candidate is FTX-6058, which is developed for the treatment of certain hemoglobinopathies, including sickle cell disease (SCD). In addition to product candidate development, the Company has developed a drug discovery approach that it employs to systematically identify and validate cellular drug targets that can potentially modulate gene expression to treat known root causes of genetically defined rare diseases. The Company has developed pociredir, which is designed to elevate the level of fetal hemoglobin, or HbF, for the treatment of people with SCD.
Contact Information
- Headquarters
- 26 Landsdowne StreetCAMBRIDGE, MA, United States 02139
- Phone
- 617-651-8851
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Kate Haviland
- President, Chief Executive Officer, Principal Financial Officer, Director
- Alex Sapir
- Chief Financial Officer, Treasurer
- Alan Musso
- Executive Vice President - Patient Affairs
- Mel Hayes
- Chief Regulatory Affairs and Quality Assurance Officer
- Heather Faulds
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $214.7M |
|---|---|
Revenue (TTM) | $81.6M |
Shares Outstanding | 62.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.31 |
EPS | $-0.35 |
Book Value | $3.80 |
P/E Ratio | -9.8x |
Price/Sales (TTM) | 2.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
